G1 raises $47M in C round

G1 Therapeutics Inc. (Research Triangle Park, N.C.) raised $47 million in an untranched series C round led by new investor Cormorant Asset Management.

New investors including Aju IB Investment, Cowen Private Investments, Franklin Templeton Investments and Rock Springs Capital also participated, as did existing investors Eshelman Ventures, Hatteras Venture Partners, Lumira Capital, MedImmune Ventures, Mountain Group Capital, RA Capital and Tavistock Life Sciences. ...